Christopher J. Senner Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 4 days, 5 hours ago
Christopher J. Senner has an estimated net worth of at least $64.4 million*, as of May 28, 2026. They own 952,317 shares of EXEL stock. They have sold 474,110 shares of EXEL stock since 2021, for an estimated $16.1 million.
Christopher J. Senner $EXEL SEC Form 4 Insider Trading
Christopher J. Senner has filed a total of 8 insider trades in $EXEL since 2021. Their most recent trade was a sale of 34,901 shares, made on May 18, 2026. Their largest trade was a sale of 125,000 shares, made on Aug 09, 2024. We estimate that they now own 952,317 shares of $EXEL, worth an estimated $48.3 million.
Insider Trading at $EXEL
There have been a total of 133 insider trades reported at $EXEL since 2021, with 762,941 shares purchased and 4.1 million shares sold. The most active insider traders in $EXEL stock have been Patrick J. Haley, Jeffrey Hessekiel, and Dana Aftab. The most recent trade was a sale of 43,451 shares reported by Dana Aftab (EVP, Research and Development), made on May 26, 2026.
History of Insider Stock Trades by Christopher J. Senner
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
EXEL
|
Sale | 34,901 | May 18, 2026 | May 19, 2026, 6:58 p.m. |
|
EXEL
|
Sale | 34,278 | Feb 13, 2026 | Feb. 18, 2026, 9:49 p.m. |
|
EXEL
|
Sale | 30,617 | Feb 17, 2026 | Feb. 18, 2026, 9:49 p.m. |
|
EXEL
|
Sale | 100,000 | May 16, 2025 | May 16, 2025, 8:58 p.m. |
|
EXEL
|
Sale | 29,314 | Feb 24, 2025 | Feb. 26, 2025, 9 p.m. |
|
EXEL
|
Sale | 125,000 | Aug 09, 2024 | Aug. 9, 2024, 7:31 p.m. |
|
EXEL
|
Sale | 60,000 | Aug 03, 2023 | Aug. 7, 2023, 9:20 p.m. |
|
EXEL
|
Sale | 60,000 | Aug 04, 2023 | Aug. 7, 2023, 9:20 p.m. |
$EXEL Executives and Stock Owners with Insider Trades
-
Patrick J. Haley, EVP, Commercial
-
Jeffrey Hessekiel, EVP, General Counsel & Sec
-
Dana Aftab, CSO/EVP Disc & Trans Research
-
Christopher J. Senner, EVP and CFO
-
Peter Lamb, EVP, Scientific Strategy & CSO
-
Jeffrey Hessekiel, EVP & General Counsel
-
Dana Aftab, EVP, Research and Development
-
Jeffrey Hessekiel, EVP and General Counsel
-
Brenda Hefti, SVP and General Counsel
-
Amy C. Peterson, EVP Prod Dev & Med Aff & CMO
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.